|
| |
 |
Oxford Gene Technology and Integrated
Genomics to Develop a Pichia pastoris Gene Expression Microarray
|
Oxford /Chicago, March 06, 2007 – Oxford Gene Technology (OGT) and
Integrated Genomics (IG) today announced the signing of a
collaboration to develop and market a Pichia pastoris Gene
Expression (GE) oligonucleotide microarray.
The collaboration gives OGT access to IG’s proprietary Pichia
pastoris genomic sequence for the design and development of a high
quality optimised 60 mer oligonucleotide microarray using the ink
jet in-situ synthesis (IJISS) platform. OGT will market the array
worldwide, and offer a sample analysis service at its Oxford
laboratory.
Mr James Clough, Commercial Director at OGT said: “We are delighted
to be working with Integrated Genomics. The combination of OGT’s
oligonucleotide array expertise combined with Integrated Genomics
sequence and detailed Pichia genome annotations will be a powerful
molecular research tool for the Pichia community and add strength to
our growing portfolio.”
Dr Theresa Walunas, Vice President of Integrated Genomics added:
“OGT’s IJISS technology provides an important new capability to the
Pichia research community. Microarrays will allow researchers to
understand how Pichia’s gene expression changes in response to
genetic modifications.”
- ENDS -
For further information, please contact:
At Oxford Gene Technology:
Nicola Booton-Mander, Marketing Manager
Oxford Gene Technology
Begbroke Science Park,
Sandy Lane, Yarnton
Oxford OX5 1PF
T: +44 1865 856352
F: +44 1865 842116
E: services@ogt.co.uk
W: www.ogt.co.uk
At Integrated Genomics:
Vinayak Kapatral, Ph.D.
Vice President, Business Development
Integrated Genomics
312-491-0846 x 326
vinayak@integratedgenomics.com
Media Enquiries:
Annabel Entress, 0207 268 3002 /
a.entress@northbankcommunications.com
Sarah Jeffery, 0207 268 3002 /
s.jeffery@northbankcommunications.com
Notes to editors
About Oxford Gene Technology
Founded in 1995 by the pioneer of Southern Blotting, Professor Sir
Edwin Southern, OGT operates out of Begbroke Business Park near
Oxford, with excellent access to a growing network of life science
companies.
· OGT offers a comprehensive custom microarray consultancy service,
from experimental design through all stages to data analysis and
interpretation. It has a strong proven track record in providing
custom microarray service in a range of applications, and recently
announced the launch of its first microarray product, an Escherichia
coli K12 ChIP on chip, the first ChIP microarray product to be
launched as part of OGT’s Prokaryotic Chip2 family
The key focus areas of OGT include:
1. Array-based application products and services for life science
research and molecular diagnostics. OGT’s flexible and
cost-effective, customised DNA microarray service covers a range of
applications, offering specialist support and assisting customers
with every aspect of their research, from initial consultation and
experimental design to probe selection, array design and fabrication
through to data analysis and interpretation
2. Development of innovative platform products for clinical research
and diagnostics
3. Licensing. OGT operates an open licensing policy which has
successfully provided access for a number of companies to OGT's
fundamental intellectual property, particularly in the area of
microarrays
4. Scientific collaborations to generate diagnostic biomarker
intellectual property
For further information on OGT visit
http://www.ogt.co.uk/
About Integrated Genomics
Integrated Genomics (
www.integratedgenomics.com ) provides bioinformatics products
and services for the life science industry, with a recent focus on
the use of in silico strategies for comparative genomics. The
company’s expertise in industrial and medicinal microbial genomics
includes genome sequencing, genome analysis and custom
bioinformatics. IG has developed ERGO™, the most advanced and
comprehensive bioinformatics suite for microbial genomics on the
market. ERGO contains the largest available integration of microbial
genome data, including genome-derived metabolic reconstructions and
representing the chemical reaction networks of metabolic pathways.
- ENDS -
|
|
| |
|
